Consensus Statement on Use of Continuous Subcutaneous Insulin Infusion Therapy in the Hospital

Bithika Thompson, Mary Korytkowski, David C. Klonoff, Curtiss B. Cook

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

In May 2017, the Diabetes Technology Society convened a panel of US experts on inpatient diabetes management to discuss the current and potential role of continuous subcutaneous insulin infusion (CSII) therapy in the hospital. The panel (1) discussed evidence for current use of CSII in the hospital, (2) recommended contraindications for use in the hospital, and (3) recommended guidelines to maximize chances for safe use of CSII in the hospital. Panel members agreed that larger, prospective, randomized studies are needed to evaluate safety and efficacy of CSII use in the hospital. As CSII technology becomes more complex and its use increases, it is imperative that institutional protocols be in place to ensure safe use of this technology and safe transitions across care areas. Providers need to be cognizant that not all patients currently using CSII as an outpatient are appropriate candidates for continued use in the hospital. This consensus statement provides guidelines for practitioners who may encounter patients using this technology in the inpatient setting.

Original languageEnglish (US)
JournalJournal of diabetes science and technology
DOIs
StateAccepted/In press - Apr 1 2018

Fingerprint

Subcutaneous Infusions
Insulin
Technology
Medical problems
Inpatients
Therapeutics
Guidelines
Outpatients
Prospective Studies
Safety

Keywords

  • continuous subcutaneous insulin infusion (CSII)
  • glucose
  • hospital
  • inpatient
  • insulin pump

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Bioengineering
  • Biomedical Engineering

Cite this

Consensus Statement on Use of Continuous Subcutaneous Insulin Infusion Therapy in the Hospital. / Thompson, Bithika; Korytkowski, Mary; Klonoff, David C.; Cook, Curtiss B.

In: Journal of diabetes science and technology, 01.04.2018.

Research output: Contribution to journalArticle

Thompson, Bithika ; Korytkowski, Mary ; Klonoff, David C. ; Cook, Curtiss B. / Consensus Statement on Use of Continuous Subcutaneous Insulin Infusion Therapy in the Hospital. In: Journal of diabetes science and technology. 2018.
@article{15a02ca497b547b3841dd44a89cd9975,
title = "Consensus Statement on Use of Continuous Subcutaneous Insulin Infusion Therapy in the Hospital",
abstract = "In May 2017, the Diabetes Technology Society convened a panel of US experts on inpatient diabetes management to discuss the current and potential role of continuous subcutaneous insulin infusion (CSII) therapy in the hospital. The panel (1) discussed evidence for current use of CSII in the hospital, (2) recommended contraindications for use in the hospital, and (3) recommended guidelines to maximize chances for safe use of CSII in the hospital. Panel members agreed that larger, prospective, randomized studies are needed to evaluate safety and efficacy of CSII use in the hospital. As CSII technology becomes more complex and its use increases, it is imperative that institutional protocols be in place to ensure safe use of this technology and safe transitions across care areas. Providers need to be cognizant that not all patients currently using CSII as an outpatient are appropriate candidates for continued use in the hospital. This consensus statement provides guidelines for practitioners who may encounter patients using this technology in the inpatient setting.",
keywords = "continuous subcutaneous insulin infusion (CSII), glucose, hospital, inpatient, insulin pump",
author = "Bithika Thompson and Mary Korytkowski and Klonoff, {David C.} and Cook, {Curtiss B.}",
year = "2018",
month = "4",
day = "1",
doi = "10.1177/1932296818769933",
language = "English (US)",
journal = "Journal of diabetes science and technology",
issn = "1932-2968",
publisher = "Diabetes Technology Society",

}

TY - JOUR

T1 - Consensus Statement on Use of Continuous Subcutaneous Insulin Infusion Therapy in the Hospital

AU - Thompson, Bithika

AU - Korytkowski, Mary

AU - Klonoff, David C.

AU - Cook, Curtiss B.

PY - 2018/4/1

Y1 - 2018/4/1

N2 - In May 2017, the Diabetes Technology Society convened a panel of US experts on inpatient diabetes management to discuss the current and potential role of continuous subcutaneous insulin infusion (CSII) therapy in the hospital. The panel (1) discussed evidence for current use of CSII in the hospital, (2) recommended contraindications for use in the hospital, and (3) recommended guidelines to maximize chances for safe use of CSII in the hospital. Panel members agreed that larger, prospective, randomized studies are needed to evaluate safety and efficacy of CSII use in the hospital. As CSII technology becomes more complex and its use increases, it is imperative that institutional protocols be in place to ensure safe use of this technology and safe transitions across care areas. Providers need to be cognizant that not all patients currently using CSII as an outpatient are appropriate candidates for continued use in the hospital. This consensus statement provides guidelines for practitioners who may encounter patients using this technology in the inpatient setting.

AB - In May 2017, the Diabetes Technology Society convened a panel of US experts on inpatient diabetes management to discuss the current and potential role of continuous subcutaneous insulin infusion (CSII) therapy in the hospital. The panel (1) discussed evidence for current use of CSII in the hospital, (2) recommended contraindications for use in the hospital, and (3) recommended guidelines to maximize chances for safe use of CSII in the hospital. Panel members agreed that larger, prospective, randomized studies are needed to evaluate safety and efficacy of CSII use in the hospital. As CSII technology becomes more complex and its use increases, it is imperative that institutional protocols be in place to ensure safe use of this technology and safe transitions across care areas. Providers need to be cognizant that not all patients currently using CSII as an outpatient are appropriate candidates for continued use in the hospital. This consensus statement provides guidelines for practitioners who may encounter patients using this technology in the inpatient setting.

KW - continuous subcutaneous insulin infusion (CSII)

KW - glucose

KW - hospital

KW - inpatient

KW - insulin pump

UR - http://www.scopus.com/inward/record.url?scp=85046793161&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046793161&partnerID=8YFLogxK

U2 - 10.1177/1932296818769933

DO - 10.1177/1932296818769933

M3 - Article

JO - Journal of diabetes science and technology

JF - Journal of diabetes science and technology

SN - 1932-2968

ER -